Growth Metrics

OmniAb (OABI) Shares Outstanding (Weighted Average) (2021 - 2026)

OmniAb (OABI) reported Shares Outstanding (Weighted Average) of $128.2 million for Q1 2026, up 21.42% year-over-year from $105.6 million in Q1 2025, and up 12.86% on a QoQ basis from $113.6 million in Q4 2025.

OmniAb (OABI) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $128.2 million in Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) rose 21.42% year-over-year to $128.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $128.2 million (up 21.42% YoY) and the FY2025 annual result came in at $113.6 million, up 11.01% from the prior year.
  • Shares Outstanding (Weighted Average) grew to $128.2 million in Q1 2026 per OABI's latest filing, from $113.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $128.2 million in Q1 2026 and bottomed at $82.6 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $100.8 million (2024), against an average of $100.0 million.
  • The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) jumped 1637.27%; it then gained 1.61% in 2024.
  • Tracing OABI's Shares Outstanding (Weighted Average) over 5 years: stood at $85.3 million in 2022, then gained by 16.84% to $99.7 million in 2023, then climbed by 2.69% to $102.4 million in 2024, then grew by 11.01% to $113.6 million in 2025, then climbed by 12.86% to $128.2 million in 2026.
  • Per Business Quant, the three latest OABI Shares Outstanding (Weighted Average) figures stand at $128.2 million (Q1 2026), $113.6 million (Q4 2025), and $108.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 177,333.76 Bn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 185,491.37 Bn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 55.66 Bn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 132.89 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 128.25 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 128.25 Mn
Dec 31, 2025 113.64 Mn
Sep 30, 2025 108.87 Mn
Jun 30, 2025 105.89 Mn
Mar 31, 2025 105.62 Mn
Dec 31, 2024 102.37 Mn
Sep 30, 2024 102.39 Mn
Jun 30, 2024 101.46 Mn
Mar 31, 2024 100.76 Mn
Dec 31, 2023 99.68 Mn
Sep 30, 2023 99.91 Mn
Jun 30, 2023 99.33 Mn
Mar 31, 2023 99.16 Mn
Dec 31, 2022 85.32 Mn
Sep 30, 2022 82.61 Mn
Jun 30, 2022 82.61 Mn
Mar 31, 2022 82.61 Mn
Dec 31, 2021 82.61 Mn
Sep 30, 2021 4.76 Mn
Jun 30, 2021 5.00 Mn
Mar 31, 2021 5.00 Mn